Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business centered on producing radioactive chemical compounds for…
Author: Helitra.com
travellinglight/iStock through Getty Images Shortly after a U.Ok. watchdog declined to endorse Biogen’s (NASDAQ:BIIB) Alzheimer’s drug Leqembi to be used within the nation’s nationwide well being…
U.Ozel.Images/E+ by way of Getty Images Although different corporations are poised to have GLP-1 receptor agonist medication for weight loss authorized, they don’t seem to be…
Zhanna Hapanovich/iStock by way of Getty Images Evolent Health (EVH) could see $35 a share in a takeover from a personal fairness agency, based on a…
Chinese medical device supplier WORK Medical prices U.S. IPO Source: Seekingalpha
Altamira Therapeutics extends distribution agreement with Pharma Nordic Source: Seekingalpha
Henrik5000/E+ through Getty Images Israel primarily based computational biology firm Evogene (NASDAQ:EVGN) mentioned on Friday it has entered into agreements with an institutional investor for the…
spawns Shares of Inhibrx Biosciences (NASDAQ:INBX) added ~8% on Friday after its Chief Executive Officer, Mark Lappe, disclosed the purchase of 40K shares of the corporate’s…
Cosmos Health (NASDAQ:COSM) has regained compliance with Listing Rule, in connection with the submitting of its 2023 Annual Report on Form 10-K and its monetary outcomes for…
Nuwellis (NASDAQ:NUWE) has entered right into a definitive securities buy settlement with sure institutional traders for the acquisition and sale of 496,901 shares of the Co.’s…